1Papaleo, E. et al., Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction. Gynecological Endocrinology, 2007, 23:12, 700 â 703. | 2Vartanyan, E.V. et al., Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization, Gynecological Endocrinology, 2017, 33:sup1, 8-11 | 3Trivax B. et al., Diagnosis of polycystic ovary syndrome. Clinical Obstetrics and Gynaecology 2007, 50(1): 168â177. | 4Unfer V. et al., Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology, 2012, 1â7 | 5Chiu T.Y. et al., Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF; relationship with oocyte quality. Human Reproduction, 2002, Vol.17, No.6 pp. 1591-1596. | 6Regidor P.-A. & Schindler, A. E., Myoinositol as a safe and alternative approach in the treatment of infertile PCOS women: a German observational study. International Journal of Endocrinology, Vol. 2016, Article I.D. 9537632, 5 pages. | 7Hoeger, K. M. et al., A patient's guide: Polycystic Ovary Syndrome (PCOS). The Journal of Clinical Endocrinology & Metabolism, 2014 Jan, 99(1): 35-36.